Liposomal prednisolone inhibits vascular inflammation and enhances venous outward remodeling in a murine arteriovenous fistula model

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wong, Chunyu ^a   Bezhaeva, Taisiya ^a   Rothuizen, Tonia C ^a   Metselaar, Josbert M ^b,c   De Vries, Margreet R ^a   Verbeek, Floris P R ^a   Vahrmeijer, Alexander L ^a   Wezel, Anouk ^a,d   Van Zonneveld, Anton Jan ^a   Rabelink, Ton J ^a   Quax, Paul H A ^a   Rotmans, Joris I ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c Enceladus Pharmaceuticals BV   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CYTOKINE; LIPOSOME; MATRIX METALLOPROTEINASE; MESSENGER RNA; PREDNISOLONE; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE C; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL; ARTERIOVENOUS FISTULA; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; GENETICS; INFLAMMATION; JUGULAR VEIN; MACROPHAGE; MALE; METABOLISM; PATHOLOGY; VASCULAR PATENCY; VASCULAR REMODELING;

ANIMALS; ARTERIOVENOUS FISTULA; CD3 COMPLEX; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; INFLAMMATION; JUGULAR VEINS; LEUKOCYTE COMMON ANTIGENS; LIPOSOMES; MACROPHAGES; MALE; MATRIX METALLOPROTEINASES; MICE, INBRED C57BL; PREDNISOLONE; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES; VASCULAR PATENCY; VASCULAR REMODELING;

EID: 84979783275     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30439     Document Type: Article

References (31)

1. Tordoir, J. H. et al. Prospective evaluation of failure modes in autogenous radiocephalic wrist access for haemodialysis. Nephrol. Dial. Transplant. 18, 378-383 (2003).
2. Rothuizen, T. C. et al. Arteriovenous access failure: more than just intimal hyperplasia? Nephrol. Dial. Transplant. 28, 1085-1092 (2013).
3. Wong, C. Y. et al. Vascular remodeling and intimal hyperplasia in a novel murine model of arteriovenous fistula failure. J. Vasc. Surg. 59, 192-201 (2014).
4. Wang, Y. et al. Venous stenosis in a pig arteriovenous fistula model-anatomy, mechanisms and cellular phenotypes. Nephrol. Dial. Transplant. 23, 525-533 (2008).
5. Nath, K. A., Kanakiriya, S. K., Grande, J. P., Croatt, A. J., Katusic, Z. S. Increased venous proinflammatory gene expression and intimal hyperplasia in an aorto-caval fistula model in the rat. Am. J. Pathol. 162, 2079-2090 (2003).
6. Kaygin, M. A. et al. The relationship between arteriovenous fistula success and inflammation. Ren Fail. 35, 1085-1088 (2013).
7. Vandevyver, S., Dejager, L., Tuckermann, J., Libert, C. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation. Endocrinology 154, 993-1007 (2013).
8. Farokhzad, O. C., Langer, R. Impact of nanotechnology on drug delivery. ACS Nano. 3, 16-20 (2009).
9. Schmidt, J. et al. Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. Brain 126, 1895-1904 (2003).
10. Lasic, D. D., Papahadjopoulos, D. Liposomes revisited. Science 267, 1275-1276 (1995).
11. Lasic, D. D. Novel applications of liposomes. Trends Biotechnol. 16, 307-321 (1998).
12. Schiffelers, R. M., Banciu, M., Metselaar, J. M., Storm, G. Therapeutic application of long-circulating liposomal glucocorticoids in auto-immune diseases and cancer. J. Liposome Res. 16, 185-194 (2006).
13. Lobatto, M. E. et al. Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis. Mol. Pharm. 7, 2020-2029 (2010).
14. van der Valk, F. M. et al. Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. Nanomedicine. 11, 1039-1046 (2015).
15. Cronstein, B. N., Kimmel, S. C., Levin, R. I., Martiniuk, F., Weissmann, G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 89, 9991-9995 (1992).
16. Rhen, T., Cidlowski, J. A. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N. Engl. J. Med. 353, 1711-1723 (2005).
17. Metselaar, J. M., Wauben, M. H., Wagenaar-Hilbers, J. P., Boerman, O. C., Storm, G. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum. 48, 2059-2066 (2003).
18. Pires, N. M. et al. Histopathologic alterations following local delivery of dexamethasone to inhibit restenosis in murine arteries. Cardiovasc. Res. 68, 415-424 (2005).
19. Schepers, A. et al. Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice. J. Vasc. Surg. 43, 809-815 (2006).
20. Villa, A. E. et al. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J. Clin. Invest 93, 1243-1249 (1994).
21. Manning, E. et al. A new arteriovenous fistula model to study the development of neointimal hyperplasia. J. Vasc. Res. 49, 123-131 (2012).
22. Hofkens, W., Schelbergen, R., Storm, G., van den Berg, W. B., van Lent, P. L. Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation. PLoS One 8, e54016 (2013).
23. Wang, M., Kim, S. H., Monticone, R. E., Lakatta, E. G. Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis. Hypertension 65, 698-703 (2015).
24. Galis, Z. S., Khatri, J. J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90, 251-262 (2002).
25. Sierevogel, M. J. et al. Oral matrix metalloproteinase inhibition and arterial remodeling after balloon dilation: an intravascular ultrasound study in the pig. Circulation 103, 302-307 (2001).
26. Nieves Torres, E. C. et al. Adventitial delivery of lentivirus-shRNA-ADAMTS-1 reduces venous stenosis formation in arteriovenous fistula. PLoS One 9, e94510 (2014).
27. Meijer, C. A. et al. Doxycycline for stabilization of abdominal aortic aneurysms: a randomized trial. Ann. Intern. Med. 159, 815-823 (2013).
28. Reil, T. D., Sarkar, R., Kashyap, V. S., Sarkar, M., Gelabert, H. A. Dexamethasone suppresses vascular smooth muscle cell proliferation. J. Surg. Res. 85, 109-114 (1999).
29. Roy-Chaudhury, P., Spergel, L. M., Besarab, A., Asif, A., Ravani, P. Biology of arteriovenous fistula failure. J. Nephrol. 20, 150-163 (2007).
30. Asif, A., Roy-Chaudhury, P., Beathard, G. A. Early arteriovenous fistula failure: a logical proposal for when and how to intervene. Clin. J. Am. Soc. Nephrol. 1, 332-339 (2006).
31. van den Hoven, J. M. et al. Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritis. Int. J. Pharm. 416, 471-477 (2011).